Home / Cardiovascular system / Valsartan and Diuretics
ATC C09DA03 · Agents Acting On The Renin-Angiotensin System
Valsartan and Diuretics shortage
As of 31 Oct 2026, Valsartan and Diuretics has a reported shortage in 5 of the 5 countries we track (Germany, Italy, Spain, Austria, Belgium), covering 32 products.
Countries5/5
Products32packs or presentations
Short since1 Jul 20188.3 years ago
Earliest return10 Nov 2026company estimate
No return date11products
Main reasonOther
Timeline
GermanyItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 160 mg/25 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| DE | VALSARTAN COMP BASICS 80 mg/12,5 mg Filmtabletten | Basics GmbH | 1 Jul 2018 | 31 Dec 2026 | Other Sonstige |
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 14 Jul 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 30 Jul 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 4 Aug 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 6 Feb 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE MYLAN | MYLAN S.P.A. | 22 Mar 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 26 Mar 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE HCS | HCS BV | 24 Apr 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | VALSARTAN E IDROCLOROTIAZIDE AUROBINDO | AUROBINDO PHARMA (ITALIA) S.R.L. | 27 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE SANDOZ | SANDOZ S.P.A. | 1 Oct 2026 | not given | Manufacturing problem Problemi produttivi: forniture discontinue |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA ITALIA | TEVA ITALIA S.R.L. | 26 Oct 2026 | 31 Jan 2027 | Increased demand Elevata richiesta |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA announced | TEVA ITALIA S.R.L. | 30 Nov 2026 | 31 Jan 2027 | Increased demand Elevata richiesta/problemi produttivi (carenza relativa solo al canale retail) |
| IT | VALSARTAN E IDROCLOROTIAZIDE PENSA announced | TOWA PHARMACEUTICAL S.P.A. | 1 Dec 2026 | 30 Jun 2027 | Increased demand Elevata richiesta/problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE TEVA ITALIA announced | TEVA ITALIA S.R.L. | 7 Dec 2026 | 31 Jan 2027 | Increased demand Elevata richiesta/problemi produttivi |
| IT | VALSARTAN E IDROCLOROTIAZIDE AUROBINDO announced | AUROBINDO PHARMA (ITALIA) S.R.L. | 22 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | VALSARTAN HIDROCLOROTIAZIDA VIATRIS 160 MG/12.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | Viatris Limited | 28 May 2026 | 27 Dec 2026 | Not stated |
| ES | VALSARTAN HIDROCLOROTIAZIDA VIATRIS 80 MG/12.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | Viatris Limited | 23 Aug 2026 | 10 Dec 2026 | Not stated |
| ES | VALSARTAN/HIDROCLOROTIAZIDA VIATRIS 320/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | Viatris Limited | 23 Aug 2026 | 10 Nov 2026 | Not stated |
| ES | CO-DIOVAN 320 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | Novartis Farmaceutica S.A. | 27 Sep 2026 | 17 Nov 2026 | Not stated |
| ES | CO-DIOVAN FORTE 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | Novartis Farmaceutica S.A. | 12 Oct 2026 | 17 Nov 2026 | Not stated |
| AT | Valsartan/HCT Sandoz 320 mg/12,5 mg - Filmtabletten, 28 Stück | Sandoz GmbH | 23 Sep 2026 | not given | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
| BE | Co-Valsartan Sandoz 160 mg - 12.5 mg film-coat. tabl. 98 | Sandoz | 15 Oct 2026 | 20 Nov 2026 | Manufacturing problem Delay in the release of the end product |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.